Sentara Hospitals
Sentara Hospitals
Norfolk, Virginia, United States4 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety, Efficacy, & Use of ViviGen Cellular Bone Matrix Allograft in Orthopaedic Fracture Care | Femoral Fractures, Fractures, Open, Fractures, Ununited, Leg Injuries, bone fracture, injury, tibia fracture | Recruiting | Not stated | 2026-09-15 | NCT04299022 | |
| JAGUAR Trial: ObJective Analysis to GaUge EVAR Outcomes Through Randomization | Aneurysm, abdominal aortic aneurysm, aortic aneurysm, aortic disorder, cardiovascular disorder, vascular disorder | Recruiting | Not applicable | 2026-09-09 | NCT05064540 | |
| Transoral Surgery Followed By Low-Dose or Standard-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With HPV Positive Stage III-IVA Oropharyngeal Cancer | DNA Virus Infections, Disease Attributes, Genital Diseases, Head and Neck Neoplasms, Infections, Neoplasms by Histologic Type, Neoplasms by Site, Otorhinolaryngologic Neoplasms, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Pharyngeal Diseases, Stomatognathic Diseases, Tumor Virus Infections, Urogenital Diseases, carcinoma, epithelial neoplasm, head and neck squamous cell carcinoma, human papilloma virus infection, infectious disease, neoplasm, otorhinolaryngologic disease, sexually transmitted disease, squamous cell carcinoma, viral infectious disease, viral sexually transmitted disease | Active, not recruiting | Phase 2 | 2026-04-01 | NCT01898494 | |
| RT With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer | Head and Neck Neoplasms, Mouth Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Stomatognathic Diseases, carcinoma, epithelial neoplasm, head and neck cancer, head and neck squamous cell carcinoma, mouth disorder, neoplasm, squamous cell carcinoma, tongue cancer, tongue disorder | Active, not recruiting | Phase 3 | 2026-01-06 | NCT00956007 |